Optimization of Methylene Blue Derivatives as Mitochondrial Therapeutic Agents for the Treatment of Freidreich's Ataxia

Project: Research project

Project Details

Description

Optimization of Methylene Blue Derivatives as Mitochondrial Therapeutic Agents for the Treatment of Freidreich's Ataxia Optimization of Methylene Blue Derivatives as Mitochondrial Therapeutic Agents For the Treatment of Friedreichs Ataxia
StatusFinished
Effective start/end date1/1/1812/31/19

Funding

  • Friedreich's Ataxia Research Alliance: $300,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.